ScholarIQanswers from OpenAlex & ORCID
Emilio Bajetta
ResearcherPublications, citations & collaboration network
Emilio Bajetta is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Emilio Bajetta have?
ScholarIQindexed works
Emilio Bajetta has 445 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Emilio Bajetta have?
ScholarIQcitation count
Emilio Bajetta has 26,351 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Emilio Bajetta?
ScholarIQh-index
Emilio Bajetta has an h-index of 65 in OpenAlex.
What is the i10-index of Emilio Bajetta?
ScholarIQi10-index
Emilio Bajetta has an i10-index of 228 in OpenAlex.
What is the OpenAlex record for Emilio Bajetta?
ScholarIQopenalex
The OpenAlex for Emilio Bajetta is on the source record.
What are the most-cited papers on Emilio Bajetta?
ScholarIQmost cited works
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
R. Charles Coombes, Emma Hall, Lorna J. Gibson, Robert Paridaens, Jacek Jassem, T. Delozier, Stephen E. Jones, Isabel Álvarez, Gianfilippo Bertelli, Olaf Ortmann, Alan S. Coates, Emilio Bajetta, David Dodwell, Robert E. Coleman, Lesley Fallowfield, E. Mickiewicz, Jørn Andersen, Per Eystein Lønning, Giorgio Cocconi, Alan L. Stewart, Nick Stuart, Claire Snowdon, M. Carpentieri, Giorgio Massimini, Judith M. Bliss
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Ihor Vynnychenko, Keunchil Park, Chih-Teng Yu, Valentyn Ganul, Jae-Kyung Roh, Emilio Bajetta, Kenneth J. O’Byrne, Filippo de Marinis, Wilfried Eberhardt, Thomas Goddemeier, Michael Emig, U. Gatzemeier
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Gianni Bonadonna, Ercole Brusamolino, Pinuccia Valagussa, Anna Rossi, Luisa Brugnatelli, Cristina Brambilla, Mario De Lena, Gabriele Tancini, Emilio Bajetta, R Musumeci, Umberto Veronesi
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R. Charles Coombes, Lucy Kilburn, CF Snowdon, Robert Paridaens, RE Coleman, SE Jones, Jacek Jassem, CJH van de Velde, T. Delozier, Isabel Álvarez, Lucia Del Mastro, Olaf Ortmann, K. Diedrich, AS Coates, Emilio Bajetta, Holmberg Sb, David Dodwell, E. Mickiewicz, J. Andersen, Per Eystein Lønning, Giorgio Cocconi, John Forbes, M. Castiglione, N Stuart, A. Stewart, Lesley Fallowfield, Gianfilippo Bertelli, Emma Hall, Richard Bogle, M. Carpentieri, E Colajori, Milayna Subar, Elizabeth Ireland, Judith M. Bliss